Your browser doesn't support javascript.
loading
Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial.
Bosaeed, Mohammad; Mahmoud, Ebrahim; Alharbi, Ahmad; Altayib, Hadeel; Albayat, Hawra; Alharbi, Faisal; Ghalilah, Khalid; Al Arfaj, Abdulmajid; AlJishi, Jumana; Alarfaj, Abdullatif; Alqahtani, Hajar; Almutairi, Badriah M; Almaghaslah, Manar; Alyahya, Nawaf M; Bawazir, Abdullah; AlEisa, Saud; Alsaedy, Abdulrahman; Bouchama, Abderrezak; Alharbi, Malak; AlShamrani, Majid; Al Johani, Sameera; Aljeraisy, Majed; Alzahrani, Mohammed; Althaqafi, Abdulhakeem O; Almarhabi, Hassan; Alotaibi, Athari; Alqahtani, Nasser; Arabi, Yaseen M; Aldibasi, Omar S; Alaskar, Ahmad.
Afiliación
  • Bosaeed M; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. bosaeedmo@ngha.med.sa.
  • Mahmoud E; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. bosaeedmo@ngha.med.sa.
  • Alharbi A; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. bosaeedmo@ngha.med.sa.
  • Altayib H; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Albayat H; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alharbi F; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Ghalilah K; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Al Arfaj A; Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • AlJishi J; Imam Abdulrahman Alfaisal Hospital, Riyadh, Saudi Arabia.
  • Alarfaj A; Department of Infectious Diseases, King Abdul Aziz Hospital, Makkah, Saudi Arabia.
  • Alqahtani H; Department of Infectious Diseases, King Salman Medical City, Madinah, Saudi Arabia.
  • Almutairi BM; King Abdulaziz Hospital- Ministry of National Guard Health Affairs, Al Ahsa, Saudi Arabia.
  • Almaghaslah M; Internal Medicine Department, Qatif Central Hospital, Al Qatif, Eastern Province, Saudi Arabia.
  • Alyahya NM; Imam Abdulrahman Al Faisal Hospital- Ministry of National Guard Health Affairs, Dammam, Saudi Arabia.
  • Bawazir A; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • AlEisa S; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alsaedy A; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Bouchama A; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Alharbi M; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • AlShamrani M; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Al Johani S; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Aljeraisy M; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alzahrani M; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Althaqafi AO; Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Almarhabi H; Department of Infectious Diseases, King Salman Medical City, Madinah, Saudi Arabia.
  • Alotaibi A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alqahtani N; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Arabi YM; Infection Prevention and Control Program, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Aldibasi OS; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alaskar A; Department of Pathology & Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Infect Dis Ther ; 10(4): 2291-2307, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34319552
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Infect Dis Ther Año: 2021 Tipo del documento: Article País de afiliación: Arabia Saudita
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Infect Dis Ther Año: 2021 Tipo del documento: Article País de afiliación: Arabia Saudita